
AC Immune SA ACIU
$ 3.25
3.83%
Annual report 2024
added 03-07-2026
AC Immune SA P/S Ratio 2011-2026 | ACIU
Annual P/S Ratio AC Immune SA
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 35 | 4.42 | 41.3 | 29.8 | 23.9 | - | - | - | - | - |
All numbers in CHF currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 41.3 | 4.42 | 26.9 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.54 | -0.7 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.8 | 1.81 % | $ 4.36 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
argenx SE
ARGX
|
311 | $ 712.23 | 1.27 % | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 228.93 | -0.91 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.39 | -6.09 % | $ 8.16 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Atea Pharmaceuticals
AVIR
|
2.11 | $ 6.15 | 1.57 % | $ 501 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 6.62 | -0.15 % | $ 181 M | ||
|
BioCardia
BCDA
|
18.6 | $ 1.35 | 6.29 % | $ 28.6 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 3.58 | -0.28 % | $ 7.79 B | ||
|
Catalyst Biosciences
CBIO
|
8.57 | $ 11.29 | -2.51 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 14.58 | 1.53 % | $ 214 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
AVEO Pharmaceuticals
AVEO
|
2.32 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.69 | 1.7 % | $ 16.9 M | ||
|
Curis
CRIS
|
1.21 | $ 0.89 | 3.74 % | $ 5.61 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 93.04 | 2.76 % | $ 27.2 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.51 | -0.33 % | $ 385 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M |